-
2
-
-
38149004988
-
-
Lek Pharmaceuticals (2004) WO Patent 071402 A2
-
Lek Pharmaceuticals (2004) WO Patent 071402 A2
-
-
-
-
3
-
-
84952652173
-
Pharmaceuticals
-
WO Patent 2004/032920 A1
-
Lek Pharmaceuticals (2004) WO Patent 2004/032920 A1
-
(2004)
-
-
Lek1
-
4
-
-
0027193852
-
-
Smith, G.B., DiMichele, L., Colwell, L.F., Jr, Dezeny, G.C., Douglas, A.W., Reamer, R.A., & Verhoeven, T.R. (1993) Tetrahedron 49, 4447-4462
-
(1993)
Tetrahedron
, vol.49
, pp. 4447-4462
-
-
Smith, G.B.1
DiMichele, L.2
Colwell Jr, L.F.3
Dezeny, G.C.4
Douglas, A.W.5
Reamer, R.A.6
Verhoeven, T.R.7
-
5
-
-
0034833612
-
-
Javemik, S., Kreft, S., Strukelj, B., & Vrecer, F. (2001) Pharmazie 56, 738-740
-
(2001)
Pharmazie
, vol.56
, pp. 738-740
-
-
Javemik, S.1
Kreft, S.2
Strukelj, B.3
Vrecer, F.4
-
6
-
-
0027434229
-
-
Kearney, A.S., Crawford, L.F., Mehta, S.C., & Radebaugh, G.W. (1993) Pharmaceut. Res. 10, 1461-1465
-
(1993)
Pharmaceut. Res
, vol.10
, pp. 1461-1465
-
-
Kearney, A.S.1
Crawford, L.F.2
Mehta, S.C.3
Radebaugh, G.W.4
-
7
-
-
0027502918
-
-
Hurley, T.R., Colson, CE., Clipper, S.A., Uhlendorf, S.E., & Reily, M.D. (1993) Tetrahedron 49, 1979-1984
-
(1993)
Tetrahedron
, vol.49
, pp. 1979-1984
-
-
Hurley, T.R.1
Colson, C.E.2
Clipper, S.A.3
Uhlendorf, S.E.4
Reily, M.D.5
-
8
-
-
0344628593
-
-
Erturk, S., Aktas, S., Ersoy, L., & Ficicioglu, S. (2003) J. Pharm. Biomed. Anal. 4, 1017-1023
-
(2003)
J. Pharm. Biomed. Anal
, vol.4
, pp. 1017-1023
-
-
Erturk, S.1
Aktas, S.2
Ersoy, L.3
Ficicioglu, S.4
-
9
-
-
84952652173
-
Pharmaceuticals
-
WO Patent 2006/008091 A2
-
Lek Pharmaceuticals (2006) WO Patent 2006/008091 A2
-
(2006)
-
-
Lek1
-
10
-
-
38149030321
-
-
ICH Topic Q3 A, Impurities in New Drug Substances, ICH Harmonized Tripartite Guidelines (March 30,1995) International Conference on Harmonization, Geneva, Switzerland
-
ICH Topic Q3 A, Impurities in New Drug Substances, ICH Harmonized Tripartite Guidelines (March 30,1995) International Conference on Harmonization, Geneva, Switzerland
-
-
-
-
11
-
-
0010285295
-
-
January 4
-
Federal Register (January 4, 1996) 61, 372-376
-
(1996)
Federal Register
, vol.61
, pp. 372-376
-
-
-
12
-
-
0001184876
-
-
November 25
-
Federal Register (November 25,1997) 62, 62890-62910
-
(1997)
Federal Register
, vol.62
, pp. 62890-62910
-
-
-
13
-
-
38149055845
-
-
ICH Topic Q1A, Stability Testing of New Active Substances and Medicinal Products (1996) ICH Harmonized Tripartite Guidelines, November 5, CPMP/ICH/280/95, International Conference on Harmonization, Geneva, Switzerland
-
ICH Topic Q1A, Stability Testing of New Active Substances and Medicinal Products (1996) ICH Harmonized Tripartite Guidelines, November 5, CPMP/ICH/280/95, International Conference on Harmonization, Geneva, Switzerland
-
-
-
-
14
-
-
38149068421
-
-
ICH Topic Q2B, Validation of Analytical Procedures: Methodology (1996) ICH Harmonized Tripartite Guidelines, November 6, CPMP/ICH/281/95, International Conference on Harmonization, Geneva, Switzerland
-
ICH Topic Q2B, Validation of Analytical Procedures: Methodology (1996) ICH Harmonized Tripartite Guidelines, November 6, CPMP/ICH/281/95, International Conference on Harmonization, Geneva, Switzerland
-
-
-
|